Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Clinical Trial Sponsors: Establishment and Operation of Clinical Trial Data Monitoring Committees.

The article reports on a notice issued by the U.S. Food and Drug Administration (FDA) inviting public comments on the proposed information collection in accordance with the U.S. Paperwork Reduction Act of 1995. The FDA has also submitted to the U.S. Office of Management and Budget (OMB) for review and clearance of the collected information. The FDA is seeking comments from public related to it on or before May 21, 2012.